Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R, Minisola S
Unità di Reumatologia, Dipartimento di Medicina, Università di Verona, Roma, Italia.
Reumatismo. 2011 Nov 9;63(3):129-47. doi: 10.4081/reumatismo.2011.129.
The Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) has elaborated the following guidelines about the definition, prevention and treatment of inadequate vitamin D status. The highlights are presented here. Daily vitamin D allowance ranges from 1,500 IU (healthy adults) to 2,300 IU (elderly with low calcium intake). Since the average Italian diet includes around 300 IU/day, subjects with no effective sun exposure should be supplemented with 1,200-2,000 IU vitamin D per day. The serum 25-hydroxy-vitamin D [25(OH)D] levels represents the most accurate way to assess vitamin D repletion, even though there are still no standardized assay methods. Conditions of “deficiency” and “insufficiency” are defined by the following ranges of 25(OH)D levels: less than 20 ng/ml and 20-30 ng/ml, respectively. In Italy, approximately 50% of young healthy subjects have vitamin D insufficiency during the winter months. The prevalence of deficiency increases with ageing, affecting almost all elderly subjects not on vitamin D supplements. When a condition of deficiency has been identified, a cumulative dose of 300,000-1,000,000 IU, over 1-4 weeks is recommended. In subjects recently treated for deficiency-insufficiency, a maintenance dose of 800-2,000 IU/day (or weekly equivalent) is recommended. In patients on daily doses over 1,000 IU, 25(OH)D levels should be checked regularly (e.g. once every two years). The highest tolerated daily dose has been identified as 4,000 IU/day. Vitamin D supplementation should be carefully monitored in patients at higher risk of vitamin D intoxication (granulomatosis) or with primary hyperparathyroidism. In pregnant women, vitamin D supplements should be given as in non-pregnant women, but bolus administration (i.e.: single dose >25,000 IU) should be avoided.
意大利骨质疏松症、矿物质代谢与骨病学会(SIOMMMS)已制定了以下关于维生素D水平不足的定义、预防和治疗的指南。以下是要点内容。每日维生素D摄入量范围为1500国际单位(健康成年人)至2300国际单位(钙摄入量低的老年人)。由于意大利人的日常饮食中约含300国际单位/天,因此没有有效日照的人群应每天补充1200 - 2000国际单位的维生素D。血清25 - 羟基维生素D [25(OH)D]水平是评估维生素D补充效果的最准确方法,尽管目前仍没有标准化的检测方法。“缺乏”和“不足”的情况由以下25(OH)D水平范围定义:分别为低于20纳克/毫升和20 - 30纳克/毫升。在意大利,大约50%的年轻健康受试者在冬季会出现维生素D不足。缺乏的患病率随年龄增长而增加,几乎影响到所有未补充维生素D的老年人。当确定存在缺乏情况时,建议在1 - 4周内累积剂量为300,000 - 1,000,000国际单位。对于近期因缺乏 - 不足而接受治疗的受试者,建议维持剂量为800 - 2000国际单位/天(或等效的每周剂量)。对于每日剂量超过1000国际单位的患者,应定期检查25(OH)D水平(例如每两年检查一次)。已确定每日最高耐受剂量为4000国际单位/天。对于维生素D中毒(肉芽肿病)风险较高或患有原发性甲状旁腺功能亢进的患者,应仔细监测维生素D补充情况。对于孕妇,维生素D补充应与非孕妇相同,但应避免大剂量给药(即单次剂量>25,000国际单位)。